Online edition of India's National Newspaper
Thursday, Dec 04, 2008
ePaper | Mobile/PDA Version
Google



Karnataka
News: ePaper | Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts:
Retail Plus | Classifieds | Jobs | Obituary |

Karnataka Printer Friendly Page   Send this Article to a Friend

They are positively happy

Staff Reporter

Bangalore: The landmark judgment by a Madras High Court Bench on Tuesday setting aside the patent granted to Roche for a drug Valganciclovir, which treats an opportunistic eye infection that affects people living with HIV, was welcomed by Karnataka Network of People Living with HIV (KNP+) here on Wednesday.

The judgment was delivered on Tuesday in a petition filed by the Indian Network for People Living with HIV/AIDS (INP+) and Tamil Nadu Networking People with HIV/AIDS (TNNP+), who had challenged the Indian Patent Office’s decision to grant a patent without hearing the pre-grant opposition filed by them in July 2006.

Printer friendly page  
Send this article to Friends by E-Mail



Karnataka

News: ePaper | Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts:
Retail Plus | Classifieds | Jobs | Obituary | Updates: Breaking News |



News Update



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | Publications | eBooks | Images | Ergo | Home |

Copyright © 2008, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu